Tin tức & Cập nhật

Hepatitis B vaccine with TLR-9 agonist achieves high protection in people with HIV
Hepatitis B vaccine with TLR-9 agonist achieves high protection in people with HIV
25 Oct 2022 bởiTristan Manalac

Among people living with HIV (PLHIV), immunization with a hepatitis B surface antigen (HBsAg)-based vaccine adjuvanted with a toll-like receptor (TLR)-9 agonist can induce a 100-percent seroprotection rate, according to a study presented at the recently concluded Virtual ID Week 2022.

Hepatitis B vaccine with TLR-9 agonist achieves high protection in people with HIV
25 Oct 2022
Treatment failure risk in older IBD patients higher with vedolizumab vs TNF antagonists
Treatment failure risk in older IBD patients higher with vedolizumab vs TNF antagonists
25 Oct 2022

The use of vedolizumab in the treatment of older patients with inflammatory bowel disease (IBD) appears to not only pose a higher risk of treatment failure but also offer no significant safety advantage when compared with tumour necrosis factor (TNF) antagonists, according to a study.

Treatment failure risk in older IBD patients higher with vedolizumab vs TNF antagonists
25 Oct 2022
Baseline HRQOL predicts survival in after radical prostatectomy
Baseline HRQOL predicts survival in after radical prostatectomy
24 Oct 2022
Poor sleep quality, depression predict sexual dysfunction in women
Poor sleep quality, depression predict sexual dysfunction in women
23 Oct 2022